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Abstract
Messenger RNA splicing is an essential and complex process for the removal of intron sequences. Whereas the composition
of the splicing machinery is mostly known, the kinetics of splicing, the catalytic activity of splicing factors and the
interdependency of transcription, splicing and mRNA 39 end formation are less well understood. We propose a stochastic
model of splicing kinetics that explains data obtained from high-resolution kinetic analyses of transcription, splicing and 39
end formation during induction of an intron-containing reporter gene in budding yeast. Modelling reveals co-transcriptional
splicing to be the most probable and most efficient splicing pathway for the reporter transcripts, due in part to a positive
feedback mechanism for co-transcriptional second step splicing. Model comparison is used to assess the alternative
representations of reactions. Modelling also indicates the functional coupling of transcription and splicing, because both
the rate of initiation of transcription and the probability that step one of splicing occurs co-transcriptionally are reduced,
when the second step of splicing is abolished in a mutant reporter.
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Introduction
The splicing of precursor messenger RNA (pre-mRNA) is an
essential process in the expression of most eukaryotic genes. The
five small nuclear ribonucleoproteins (snRNPs) and the many non-
snRNP-associated proteins that constitute the splicing machinery,
assemble anew on each precursor RNA to form the spliceosome
complex that catalyses the two chemical reactions of splicing [1].
Both the spliceosome components and the spliceosome assembly
process are largely conserved between human and yeast. The
complexity of the spliceosome is indicated by the *170 proteins
that are associated with it [1]. Adding to the complexity, splicing
may occur partly, or entirely, concurrently with transcription. In
eukaryotes, the interaction of the spliceosome with the precursor
RNA can be considered to be an allosteric cascade in which early
recognition steps induce conformational changes required for
subsequent steps and for catalytic activation (reviewed by [2]).
However, the wealth of knowledge of molecular interactions,
obtained mainly through extensive biochemical and genetic
analyses, has yet to be formalised as a systems model of
transcription and splicing.
Spliceosome assembly is thought to occur via a series of events
with many points of regulation [3]. In the first step, U1 snRNP
binds to the 59 splice site (59SS), followed by the U2 snRNP at the
branchsite. The U4, U5 and U6 snRNPs join as a tri-snRNP
complex and, after the association of other, non-snRNP proteins,
the spliceosome complex is activated for the first chemical step of
splicing. The 59 splice site is cleaved and, simultaneously, the 59
end of the intron becomes covalently attached to the branchsite to
form a branched, lariat structure. In the second step, the 39 splice
site (39SS) is cleaved, which excises the intron, and the exons are
joined to produce the mature mRNA. Between the two steps of
splicing, a conformational change is required in the catalytic
centre of the spliceosome [4], and at several stages during the cycle
of spliceosome assembly, splicing and spliceosome dissociation,
proofreading mechanisms are thought to operate [5]. Nascent
transcripts also have to be matured at their 39 end, by cleavage
and polyadenylation. Figure 1 A illustrates spliceosome assembly
and the two steps of splicing for a pre-mRNA with one intron that
has already been polyadenylated and released from the DNA
template.
Splicing can also occur co-transcriptionally, prior to 39 end
maturation (Figure 1 B), and there is considerable experimental
evidence for functional coupling of transcription, splicing and 39
end maturation in vivo [6–12]. However, little is known about the
impact of coupling on kinetic rates. Splicing has been modelled,
but not to the same level of detail as transcription, and models of
transcription have yet to fully incorporate the splicing reaction.
Quantifying the dynamics of these processes remains a challenge
[13], and modelling may have an important role to play in
distinguishing functional dependencies from coincidental and
contemporaneous effects, and in identifying and characterising
the interactions that effect coupling.
Existing models of splicing have allowed splicing efficiency to
be defined [14], and have shown that transcription by RNA
polymerase II (Pol II) greatly increases splicing efficiency in
PLoS Computational Biology | www.ploscompbiol.org 1 October 2011 | Volume 7 | Issue 10 | e1002215comparison with transcription by T7 polymerase [15]. A
correlation between splicing efficiency and the pausing of Pol II
on short terminal exons has been reported [11]. Splicing has been
represented as a single irreversible reaction that creates the
product mRNA from pre-mRNA [11,14], and as a single
irreversible reaction that creates mRNA from the pre-mRNA+
spliceosome complex [15]. To-date, steps one and two of splicing
have not been modelled as separate reactions, nor have the co-
and post-transcriptional splicing pathways been distinguished.
Further insights into splicing can be expected by more detailed
modelling and analysis.
As noted above, splicing can occur during messenger RNA
transcription. Transcription begins with the assembly of the pre-
initiation complex at the promoter. This complex includes Pol II,
which, after initiation, begins the transcript elongation process that
transcribes DNA into RNA. Early in elongation, the pre-mRNA is
capped at its 59 end by the capping enzymes. Elongation involves a
sequence of many hundreds of individual polymerisation reactions,
and hence the time required to complete the elongation of a
transcript is predicted to have less variability than a single-step
process with an equivalent rate [16,17]. The mature 39 end of the
RNA is formed by an endonucleolytic cleavage at the so-called
poly A site and the newly formed 39 end is extended by
polyadenylation (reviewed by [18]). The elongation process and
Figure 1. Post-transcriptional and co-transcriptional splicing. A) Spliceosome assembly begins with the U1 and U2 snRNPs. On the post-
transcriptional splicing pathway, polyadenylated pre-mRNA is spliced (step one) to produce polyadenylated lariat-exon2, from which mature mRNA
results on completion of step two. B) Splicing can occur during transcript elongation on the co-transcriptional splicing pathway. The RNA polymerase
Pol II (shown in green) transcribes Exon1, the Intron and Exon2 (colours of the RNA indicate the corresponding region of the DNA, and the red oval
indicates the cap on the 59 end of the RNA). Splicing can occur after the transcription of specific sequences that trigger the assembly and activation of
the spliceosome on the RNA. C) The transcription and splicing pathway. A polymerase proceeds from the active promoter complex (APC) through 15
irreversible steps that represent the transcription of nucleotides in Exon 1 and the Intron up until the branchsite. From the branchsite (e15) until the
end of Exon 2, a transition can be made to the co-transcriptional splicing path fi as the first step of splicing can occur. The characteristics of post-
transcriptional splicing steps one and two (kspl1p and kspl2p), and co-transcriptional splicing step two (kspl2c) are determined by model comparison.
doi:10.1371/journal.pcbi.1002215.g001
Author Summary
The coding information for the synthesis of proteins in
mammalian cells is first transcribed from DNA to messen-
ger RNA (mRNA), before being translated from mRNA to
protein. Each step is complex, and subject to regulation.
Certain sequences of DNA must be skipped in order to
generate a functional protein, and these sequences,
known as introns, are removed from the mRNA by the
process of splicing. Splicing is well understood in terms of
the proteins and complexes that are involved, but the
rates of reactions, and models for the splicing pathways,
have not yet been established. We present a model of
splicing in yeast that accounts for the possibilities that
splicing may take place while the mRNA is in the process
of being created, as well as the possibility that splicing
takes place once mRNA transcription is complete. We
assign rates to the reactions in the pathway, and show that
co-transcriptional splicing is the preferred pathway. In
order to reach these conclusions, we compare a number
of alternative models by a quantitative computational
method. Our analysis relies on the quantitative measure-
ment of messenger RNA in live cells - this is a major
challenge in itself that has only recently been addressed.
Kinetics of Co-Transcriptional Splicing
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modelling transcription [16].
The recruitment of Pol II enzymes and spliceosomal proteins are
important steps in transcription and splicing, but are not believed to
be rate limiting under normal conditions. Kinetic studies of Pol II
complexes indicate that a minority of them are actively involved in
transcription at any given time. The remainder move by diffusion
through the nucleus [19], as do the product mRNA molecules [20].
Three kinetically distinct populations of Pol II have been identified
at the site of transcription; those bound to the promoter, those
initiating transcription, and those engaged in elongation [21]. The
movement of the spliceosomal proteins that catalyse the splicing
reactions can be modelled as Brownian diffusion [22]: these RNPs
move continuously throughout the nucleus independently of
transcription and splicing.
We have developed a stochastic model that represents splicing in
the context of transcript elongation and RNA 39 end maturation, as
shown diagrammatically in Figure 1 C. (All pathway models are
provided as files in Dataset S1.) A stochastic formulation allows the
effects of small numbers of molecules to be explored, and
simulations of the model can be averaged in order to obtain the
population mean over time. Experimental values for the model
species (population averages in copies/cell), including fully-spliced
mRNA (see Materials and Methods) and two precursor species in
both 39 uncleaved and cleaved/polyadenylated forms, have been
obtained by a rapid sampling protocol that is capable of capturing
transient species [23].We first describethestructure of the pathway,
then present the data, and subsequently discuss alternative
representations of the steps in the RNA pathway in the light of
the data. The simplest description that might be adopted for
the elongation, 39 end formation and splicing steps is a single
irreversible reaction.However, we find this provides a poor fit to the
available data, and consequently a number of alternative represen-
tations for these reactions are considered. The extent to which the
alternative pathways fit the data is assessed by the Akaike
information criterion (AIC) for optimal parameter choices.
Results
Modelling transcription and splicing
We propose a multistep model for transcription by dividing
the gene into sections to be transcribed. Each section (ei) of the
reporter DNA represents approximately 30 nucleotides, corre-
sponding to the footprint of Pol II on the DNA [24]. As the length
of the Ribo1 reporter (described below) used in the experimental
studies is 1240 bases, we define 40 sections of DNA: e1::e40. Each
section of DNA can be occupied by at most one Pol II, and the
progression of Pol II from the 59 to the 39 end of the gene is
equated with successful extension of the transcript. The number of
sections of DNA defines an upper limit on Pol II occupancy, and
can limit the effective rate at which a Pol II can complete
elongation. Beginning with the initiation of transcription, the ki
reaction (see Figure 1 C) places a Pol II enzyme in the active
promoter complex (APC) when the gene is active. Thereafter, this
Pol II can progress along the gene at elongation rate ke (the
number of sections of DNA transcribed per unit of time). Letting
the rate of polymerisation of nucleotides be kp (the number of
nucleotides incorporated per unit of time): ke~kp=n. (Equivalent-
ly, the mean time for n polymerisation events: StnT~n=kp, equals
the mean time for one elongation event: 1=ke). This multistep
model of elongation is comparable with the kinetic model of Pol I
elongation proposed in [25]. The pathway proposed here does not
include a transition between active and inactive states of the
promoter, as the rapid rate of mRNA production does not indicate
that the promoter switches off during the period immediately after
induction. However, such a transition is needed to explain the
mRNA distribution in steady state [26] and can easily be included
in this model.
Kinetic competition between splicing and elongation has been
discussed extensively [8,27,28], and is modelled here as taking
place at the sections of DNA after the branchsite. In these sections,
the occurrence of the first step of splicing of an RNA is represented
in the model by a change of state of the associated Pol II, which
can make a transition to the co-transcriptional splicing path fi.
Sections ei and fi represent the same n nucleotides of the DNA and
so at most one of these sections can be occupied (by at most one
Pol II). The rate for the transition between splicing pathways is 0
prior to the completion of the splicing activation process. The
splicing activation process is triggered at rate ka when the gene
switches on. When splicing is active, the transition rate is ke=cs,
where cs is a constant that determines the ratio of the competing
reactions (elongation and splicing) and thereby the probability of
co-transcriptional splicing. Activation of co-transcriptional splicing
involves co-transcriptional spliceosome assembly as well as the first
step splicing reaction (i.e. co-transcriptional spliceosome assembly
alone is not sufficient). Each Pol II completes elongation either at
f40, having completed the first step of splicing, or at e40 having
failed to do so. Subsequently, on the post-transcriptional path, 39
end maturation (kcpr1) produces polyadenylated pre-mRNA, step
one of splicing (kspl1p) produces polyadenylated lariat-exon2, and
step two of splicing (kspl2p) produces mature mRNA and lariat, as
indicated in Figure 1 C. On the co-transcriptional pathway, the
second step of splicing (kspl2c) produces uncleaved mRNA and
lariat, and 39 end maturation (39 cleavage, polyadenylation and
release; kcpr2), produces mature mRNA. It is important to note
that the species measured experimentally are pre-mRNA, lariat-
exon2 (the branched lariat structure) and mRNA, and that the
uncleaved and polyadenylated forms can also be distinguished (as
illustrated in in Figure 1 C). The assays for these species are
described below.
Initial estimates for some parameters can be obtained from the
literature: the rate of initiation of transcription in yeast has been
estimated as 0:125{0:2s{1 [29,30]. Polymerisation rates in the
mammalian nucleus of up to 72 nucleotides/s have been reported
for polymerases that do not pause. This is a significant increase on
earlier estimates of 18–42 nucleotides/s [13] that may reflect an
average or effective rate. A Pol I elongation rate of 90 nucleotides/s
has been reported [25]. The time for pre-mRNA 39 cleavage in
HIV-1 has been reported to be 55 s, with release taking 9 s [16].
The probability of co-transcriptional splicing is not known, and this,
along with precise values for all other parameters, will be inferred
from fitting the pathway to the data.
Splicing and 39 end cleavage assays
The pathway was developed to explain data from the Ribo1
reporter [23]. Ribo1 is a chimeric yeast gene that contains the
single intron from the ACT1 gene and the 39 end processing signal
from PGK1, as shown in Figure 2 A (modified from [31]). The
reporter gene is integrated in the genome, transcribed under the
control of a doxycycline-responsive promoter in a doxycycline-
inducible strain of Saccharomyces cerevisiae. By modelling splicing in
this reporter, we aim to define the splicing pathways and to
quantify reaction rates. The impact of splice site mutations on the
coupling between splicing and transcription can also be explored.
Three replicate experiments were performed in which doxycy-
cline was added to a culture to induce reporter gene expression,
and transcript levels were measured by reverse transcription and
real-time quantitative PCR (RT-qPCR; see Materials and
Kinetics of Co-Transcriptional Splicing
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pre-mRNA, lariat-exon2, and mRNA. The RT-qPCR data were
converted to copies per cell (see Materials and Methods; [23]),
which allows a quantitative comparison of data obtained for the
different RNA species and from different cultures. The merged
time series derived from three biological replicates for Ribo1 is
shown in Figure 2 B (referred to as Expt 1). In the 120 s interval
420 s–540 s after the addition of doxycycline to the cell culture,
the level of Ribo1 mRNA increases from 11 to 45 copies/cell
(Figure 2 B). Messenger RNA then reaches 60 copies/cell, on
average, 180 s later. The high level of mRNA is notable, as is the
rapid rate of transcript synthesis. The delay between the rise in
pre-mRNA and the rise in mRNA may indicate a slow, or delayed,
splicing reaction. In the substantive phase of transcriptional
activity (after 420 s in Figure 2 B), the levels of pre-mRNA and
lariat intermediate are only a fraction of the mature mRNA
species which shows that the first and second steps of splicing must
be rapid.
To investigate the effects of blocking the first or second step of
splicing, two modified Ribo1 reporters were created with point
mutations at the 59 splice site (59SSRibo1) or 39 splice site
(39SSRibo1) respectively [23]. The mutant reporters were induced
with doxycycline and the splicing intermediates detected using the
primers shown in Figure 2 A. The merged time series for
Figure 2. The Ribo1 reporter and its response to doxycycline. (A) Schematic of the promoter, intron and exons of Ribo1. The positions of the
RT-qPCR primers are shown by the arrow C1. (B) Induction and splicing of Ribo1 measured by RT-qPCR. (C) Induction and step 1 splicing of 39SSRibo1.
Step two of splicing is blocked and therefore mRNA is not produced. (D) Induction of 59SSRibo1. Step one of splicing is blocked and therefore neither
lariat-exon2 nor mRNA is produced. Points indicate pre-mRNA (blue), lariat-exon2 (green) and mRNA (black) data. Error bars show the standard error
of three biological replicates. Solid lines are model predictions.
doi:10.1371/journal.pcbi.1002215.g002
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respectively. As indicated by the error bars in Figure 2 C, the
synthesis of lariat-exon2 in the mutant reporter varied between
biological replicates, but technical error within each replicate
remained at typical levels. The level of pre-mRNA measured in
the modified reporters is greater than was observed for Ribo1.
This may be attributed to changes in the rates of transcript
synthesis, splicing step one or degradation, and modelling can help
to resolve this question.
For practical reasons, co-transcriptional splicing is defined here
as splicing that is completed before the transcript has been released
from the transcription complex by 39 end cleavage. The data
shown in Figure 2 were produced using a cDNA primer that
hybridises to exon2 (at position C1 in Figure 2 A), which does not
distinguish between transcripts that are cleaved and polyadenyl-
ated or uncleaved at the 39 end. Therefore, in order to differentiate
between these species and to estimate the rates for 39 end
formation, a modified 39 cleavage assay used two alternative
primers for cDNA synthesis from 39 end sequences of Ribo1; oligo
(dT), anneals to cleaved and polyadenylated transcripts, whereas
primer C2 is complementary to a sequence downstream of the
mapped 39 end cleavage sites (Figure 3 A; [23]). By amplifying
these cDNAs with specific primers for detection of pre-mRNA,
lariat-exon2 and mRNA (Figure 3 A), uncleaved and cleaved/
polyadenylated pre-mRNA, lariat-exon2 and mRNA were
successfully distinguished in Expt 2 (Figure 3 B and 3 C).
The 39 cleavage assay detected a sharp, transitory peak in
uncleaved pre-mRNA at 540 s, followed by a similar peak in
polyadenylated pre-mRNA 30 s later (Figure 3 B). This indicates
pre-mRNA that is not spliced prior to 39 end cleavage, i.e. is not
spliced co-transcriptionally. However, the rapid accumulation of
uncleaved mRNA between 540 and 600 s prior to detection of
polyadenylated spliced mRNA at 600 s, clearly shows that co-
transcriptional splicing occurs before post-transcriptional splicing.
By formally modelling the splicing pathway, we aim to quantify
the extent to which mature mRNA is derived from co-
transcriptional splicing, and from post-transcriptional splicing
respectively.
The reactions in the model must be enabled (switched on)
progressively in order to explain the data. Following the induction
of transcription by doxycycline, a burst of pre-mRNA is postulated
to occur. At this time, splicing is not active, and additional
transcripts are not initiated. These initial pre-mRNAs are cleaved
and polyadenylated, and may then splice or degrade. This process
explains the accumulation of pre-mRNA in Figure 2 B, and the
peak in uncleaved pre-mRNA in the 39 cleavage data in Figure 3
B. After a delay (defined by the rate ka), splicing steps 1 and 2 and
the initiation of new transcripts start. This explains the drop in
pre-mRNA in Figure 2 B, and the peak in polyadenylated pre-
mRNA (Figure 3 B) as the activation of splicing removes these
species also. Figure 1 in Text S1 illustrates the sequence of events.
Alternative models of RNA processing steps
The proposition that there are advantages to modelling
elongation in detail can be tested. Pathways that include 40 steps
of elongation are compared with simpler pathway models where
competition between elongation and splicing step one is represented
by two reactions ke1 and ke2 that have APC as the substrate and
e40 and f40 as the respective products. The proportion of co-
transcriptional splicing can be calculated from these reaction rates
and this proportion can be compared with that predicted for the 40
step model (as defined by equation 1 in Materials and Methods).
The total time allocated to elongation can also be compared in the
alternative models.
Figure 3. The 39 cleavage and polyadenylation of Ribo1
measured by RT-qPCR. (A) Schematic of the Ribo1 gene. The
positions of the alternative cDNA primers for uncleaved and cleaved/
polyadenylated transcripts are shown by the C2 and oligo (dT) arrows
respectively. (B) Points indicate uncleaved pre-mRNA (U-pre-mRNA),
polyadenylated pre-mRNA (P-pre-mRNA) and polyadenylated lariat-
exon2 (P-lariat-exon2) data. (C) Points indicate 39 uncleaved lariat-exon2
(U-lariat-exon2), uncleaved mRNA (U-mRNA) and polyadenylated mRNA
(P-mRNA) data. Error bars show the standard error of three biological
replicates. Solid lines are model predictions.
doi:10.1371/journal.pcbi.1002215.g003
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end formation. This involves cleavage, polyadenylation and
transcript release, and requires three multi-subunit factors [32].
Polyadenylation adds up to approximately 250 nucleotides to the
end of the transcript. Hence, it is uncontroversial to model 39 end
formation as a multi-step process as many steps of maturation are
clearly required. When fitting the splicing pathway to the Ribo1
data, a much better qualitative and quantitative fit is obtained
when 39 end maturation is modelled as a five-step process (each of
the five steps has rate 5|kcpr1) in comparison with a single step
model. The characteristics of 39 uncleaved spliced RNA also fit the
data better by modelling 39 end formation in this way. As shown in
Figure 3 C, uncleaved mRNA quickly peaks towards its steady
state of 10 copies/cell rather than making a slow progression to
this level. Replacing the single step model with the 5 step model of
39 end maturation (reactions kcpr1 and kcpr2) significantly improves
the fit to the data. It is easily shown that a process of five steps,
each at the same rate, has a kinetic response that differs
significantly from that of a single step. (The distribution of waiting
times follows a gamma distribution rather than an exponential
distribution.) We do not aim to determine the exact number of
steps, rather we aim to test whether a process of multiple steps of
maturation or senescence provides a better quantitative and
qualitative explanation than a single reaction. Henceforth, we
assume that 5 steps constitute an adequate model of a multi-step
process for the purpose of testing this hypothesis. Text S2 presents
an analysis of Ribo1 degradation kinetics that further illustrates the
approach.
Genetic studies have identified many splicing factors, but their
impact on splicing kinetics in-vivo is difficult to quantify. These
factors, and the five snRNPs, are not believed to be rate-limiting
and have not been included in the model: We initially consider the
kinetics of the splicing intermediates alone. However, we find once
more that simple unimolecular models for steps one and two of
splicing do not fit the data well. Consequently, we propose two
alternative characterisations of the splicing reactions prior to
steady state, and quantify the extent to which these models
improve the fit of the pathway to the data.
The first alternative model of splicing we propose represents
these processes as a sequence of several reactions that reflect the
many known steps of spliceosome assembly. The precursors and
products of multi-step processes show sharp transitions in their
kinetics, as observed for pre-mRNA and lariat-exon2 in the
experimental data. A multi-step model of this kind has been shown
to explain fluorescence recovery after photobleaching (FRAP) data
obtained from a splicing reporter in mammalian cells [33].
The second alternative explanation of the rapid processing of
pre-mRNA and lariat-exon2 that we propose is based on the
proposition that the splicing reactions are catalysed in a manner
such that the propensity of the reaction increases on successive
splicing events. It is necessary for the initial propensity to be low as
otherwise no accumulation of splicing precursor or lariat
intermediate would be observed, and for the propensity to
increase to remove the accumulation rapidly. The reduction of
uncleaved lariat-exon2 over the period of time when mRNA
increases rapidly (600 s-700 s in Figure 3 C) may indicate such an
increase in reaction propensity: the substrate decreases while the
rate of increase of product remains constant. It therefore appears
that step two of splicing may not be governed by first-order
kinetics when it is co-transcriptional. The observations can be
modelled by positive feedback in the splicing reaction. This
requires the involvement of additional molecular species in the
splicing reaction - the enzyme Y - a role that can be played by
factors required for step two of splicing.
The following positive feedback mechanism has the property of
increasing reaction propensity: Let the enzyme Y have an initial
copy number of 1, and increment the copy number on each
splicing event to effectively increase the propensity. The enzyme
contributes to the reaction propensity according to the formula
for bimolecular reactions (precursor|Y|stochastic{rate{
constant). The positive feedback model is proposed for the kinetics
of high rates of induction prior to steady state.
Pathway comparison
Due to the uncertainties in pathway structure, and parameter
identifiability and estimation, it is of considerable value to explore
multiple models of a biological system [34]. The goodness of fit to
the experimental data of eight versions of the RNA processing
pathway is compared in Table 1. The alternative pathways are
distinguished by their representation of elongation, of co-
transcriptional splicing step two, and of post-transcriptional
splicing steps one and two. Elongation is modelled either as a
single step or as 40 steps, as described above. The alternative
models considered for the splicing reactions are: a single step,
multiple steps (each at the same rate) or positive feedback. It is
important to consider each pathway as a whole as the goodness of
fit for each observed species is dependent on the reactions that act
directly on the observed species, and those that act on its
precursors and thereby shape the kinetics of the precursors.
Table 1 defines each pathway and lists the AIC scores obtained
using the optimal parameters (see Table 1 in Text S1 for the
parameter values). Note that pathway slowromancap VIII makes
the simplest assumptions about elongation and splicing steps,
namely that they are single-step unimolecular reactions, and that
the poor fit of this pathway to the data motivates the search for
alternative models.
Pathway parameters were optimised by a simulated annealing
algorithm (see Materials and Methods; [35]) that identified the
best fit between each pathway and the nine data series obtained for
Ribo1 (those plotted in Figure 2 B, 3 B and 3 C). The total AIC
(defined in Materials and Methods) is calculated from the
Table 1. Comparison of pathways I-VIII using optimal
parameters by AIC.
Pathway Property Total AIC Akaike wt.
Co Po El
I F M M 0 0.845
II F M S 40.9 1.09e-9
III F F M 3.43 0.152
IV F F S 31.2 1.40e-7
V M M M 16.5 2.20e-4
VI M M S 36.1 1.25e-8
VII S S M 11.7 2.41e-3
VIII S S S 28.4 5.65e-7
The alternative pathways are distinguished by the representation of co-
transcriptional splicing step 2 (column Co) as a reaction that involves feedback
(F), multiple steps (M) or a single step (S); the representation of post-
transcriptional splicing steps 1 and 2 (column Po) as a F, M or S reaction; and
their representation of elongation (column El) as a M or S process. Total AIC is
calculated from all pathway model residuals in all species, and normalised by
subtracting the AIC for pathway I. Akaike weights wi are calculated from total
AIC and represent the normalised likelihood of each of the eight pathways (see
Materials and Methods, and Table 1 in Text S1 for parameter values).
doi:10.1371/journal.pcbi.1002215.t001
Kinetics of Co-Transcriptional Splicing
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pathway models are provided as files in Dataset S1. An executable
version of the Dizzy simulator [36] is also provided to allow the
models to be executed.
The AIC scores for pre-mRNA, lariat-exon2 and mRNA are
represented separately in the columns of the heat map in Figure 4.
It is apparent from the A-pre-mRNA column that all pathways fit
well to the pre-mRNA data in Expt 1, and fit to a comparable
extent. The majority of pathways also fit the mature mRNA data
well (A-mRNA and P-mRNA columns). Pathways I-IV can be
optimised to the lariat-exon2 data simultaneously. In contrast,
pathways V-VIII have a poor fit to one or more of the lariat-exon2
species. Pathway I has the best overall AIC as a result of fitting the
nine data series most consistently.
Pathways I-IV incorporate the feedback mechanism for co-
transcriptional splicing step two and this feature correlates with a
good fit (low AIC) for all lariat-exon2 species. Within these
pathways, a multi-step representation of post-transcriptional
splicing, combined with a multi-step representation of elongation
has the best overall score (pathway I). Feedback in post-
transcriptional splicing, combined with a multi-step representation
of elongation also explains the data well (III). Pathway VII is
ranked in third place, failing to explain the polyadenylated lariat-
exon2 data in Expt 2 (as indicated by the white cell in row VII,
column P-lariat-exon2 in Figure 4). The predictions of the
pathways for each of the nine species measured in Expt 1 and 2
are plotted in Figure 2 in Text S1. Important qualitative
differences between the pathways can be seen in these graphs.
Elongation and 39 end maturation are multi-step
processes. Pathways with a single elongation step require an
initiation rate of 0.4, and a rate for elongation ke2 of 0.4–0.54,
giving an implausible time of 2–3 s for the elongation of a 1240
nucleotide gene. As a consequence of defining a more realistic
elongation time, pathways with a multi-step representation of
elongation typically fit the data better, see Table 1.
In pathway I, pre-mRNA 39 end maturation takes 35 s and
uncleaved 39 end mRNA maturation takes 49 s using the measure
of the time taken for the sum of intermediate species undergoing
the five steps of 39 end processing to reduce by half (an equivalent
to the half life of a single step reaction).
Splicing is predominantly co-transcriptional for
Ribo1. The completion of splicing co-transcriptionally in yeast
has been a topic of debate. Genome-wide ChIP studies indicated
that co-transcriptional spliceosome assembly may not have time to
occur if the 39 exon is short [28]. More recent studies provide
evidence for polymerase pausing 39 of introns, suggesting a
mechanism to slow transcription, allowing more time for splicing
[10,11]. With Ribo1 we observe that the initial burst of 39
uncleaved pre-mRNA is not spliced before it is 39 end cleaved, as
shown by the successive blue and purple peaks in Figure 3 B, and it
may undergo post-transcriptional splicing. After this initial burst,
the majority of transcripts splice co-transcriptionally, as seen by
the accumulation of uncleaved lariat-exon2 and uncleaved mRNA
prior to cleaved/polyadenylated mRNA (red, green and black,
respectively in Figure 3 C). Optimisation of pathway I computes cs
to be 11.39, and by substituting this value into equation 1 (see
Materials and Methods) it follows that 12% of Ribo1 RNA
transcripts splice post-transcriptionally, and 88% of transcripts
splice co-transcriptionally. Values for cs in pathways III, V and
VII imply the same proportion of co-transcriptional splicing, as do
the values of ke1 and ke2 in the four remaining pathways where the
proportion of co-transcriptional splicing is approximately 85%.
The second step of splicing is governed by positive
feedback when co-transcriptional. Pathways I-IV show a
good qualitative fit to the uncleaved lariat-exon2 data (see
Figure 2E in Text S1). All four pathways specify a positive
feedback mechanism for kspl2c with estimated rate constants kspl2c
in the range 0.0061–0.0068 (see Table 1 in Text S1). In pathway I
, the half life of this reaction is 110 s for the first transcript to
splice, and, with feedback, the half life reduces to 5.5 s at 670 s
after induction. As, initially, the half life is much greater than the
time to transcribe exon 2 (approximately 11 s), the decision to
model the second step of splicing as a process that occurs after
elongation is justified.
The feedback mechanism may be a result of the disassembly
and recycling of the snRNPs of the spliceosome for subsequent
rounds of splicing [37]. It has been proposed that the branchpoint
binding protein (BBP) and Mud2 are recycled between two steps in
pre-spliceosome assembly: BBP is released during or after the
second step and efficiently recycled to promote the first [38]. The
finding that snRNPs do not assemble on a nascent transcript in
response to a signal, but move randomly [22], does not preclude
them impacting on splicing kinetics in a transcription-dependent
manner through an influence on rates of spliceosome assembly,
disassembly or recycling. Maintenance of the transient Cajal body
(responsible for the maturation of snRNPs) requires continuous
recycling of pre-existing snRNPs after each round of spliceosome
assembly [22], and may therefore be indirectly dependent on
transcription when splicing is co-transcriptional. If recycling
mechanisms existed for second step factors, increasing the effective
Figure 4. A heat map of AIC scores for pre-mRNA, lariat-exon2
and mRNA. A- indicates the AIC score for all species in Expt 1
(uncleaved and polyadenylated); U- AIC for uncleaved species in Expt 2;
and P- AIC for polyadenylated species in Expt 2. The spectrum red to
white reflects the lowest (best) to highest (worst) AIC score calculated
for each species using the optimal parameter values for each pathway
(rows I-VIII). Each column is normalised to have a minimum value of 0
by subtracting the minimum AIC score in the column from each entry.
doi:10.1371/journal.pcbi.1002215.g004
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uncleaved lariat-exon2 in Expt 2. The allosteric effects of second
step splicing factors would provide an alternative explanation.
Post-transcriptional splicing has multi-step charac-
teristics. Pathways I and III specify a multi-step
representation of elongation and feedback in co-transcriptional
splicing. They account for 99% of the probability mass available in
the Akaike weight analysis (see Table 1). These two pathways differ
on the post-transcriptional splicing mechanism: a multi-step
representation is more probable (P=0.845) but a feedback
mechanism cannot be ruled out (P=0.152). As pathway I has a
better fit to the polyadenylated pre-mRNA and polyadenylated
lariat-exon2 data (the precursor and products of post-
transcriptional splicing), we tentatively conclude that post-
transcriptional splicing has multi-step characteristics. The
difficulty in modelling the post-transcriptional splicing process
lies in its transient activation. The characteristic features of the
feedback mechanism are not clearly revealed. For a multi-step
model, the times for the sum of intermediate species undergoing
splicing to reduce by half are 34 s for step one and 36 s for step
two of splicing.
A mutation at the 39 splice site reduces the probability of
co-transcriptional splicing. The 39SSRibo1 data are
explained by a variation of the transcription and splicing
pathway where step one of splicing can be co-transcriptional or
post-transcriptional (as in the full pathway), but where the lariat-
exon2 species goes through the five-step cleavage process (at rate
kcpr1) instead of step two of splicing (kspl2c =0 and kspl2p =0). The
pathway used to explain the 59SSRibo1 data has no co-
transcriptional splicing path (fi cannot be reached), and no post-
transcriptional splicing can occur (kspl1p~0).
The induction of the 39SSRibo1 reporter (Figure 2 C) shows a
greater accumulation of pre-mRNA than observed for Ribo1. The
lariat-exon2 product is not spliced, but accumulates and is subject
to degradation. The data can be explained by pathway I using the
kspl1 rate inferred for Expt 1 and 2. However, to predict the pre-
mRNA response cs is increased to 30, ka is reduced to 0.015, and
ki is reduced to 0.175. The probability of step 1 occurring co-
transcriptionally is therefore reduced to 56% compared with 88%
in Ribo1, the time taken for splicing to become active increases
two fold, and the rate for the initiation of transcription reduces to
70% of the rate in Ribo1. The prediction for lariat-exon2 is
greater than observed, and this may indicate that 39 end
maturation and/or lariat-exon2 degradation pathways differ in
the mutant reporter.
The induction of 59SSRibo1 (Figure 2 D) shows that pre-mRNA
accumulates and does not splice. The response can be explained
by further reduction in ki to 0.1, that is, 40% of the rate in Ribo1.
The induction of 39SSRibo1 was repeated using the primers of
Expt 2 in order to validate the finding that the probability of co-
transcriptional splicing is reduced. The new data are shown in
Figure 3A in Text S1. The pathway model predicts only a slow
removal of the accumulating uncleaved pre-mRNA (and conse-
quently of polyadenylated pre-mRNA) that is consistent with the
new data. In contrast, the large reduction in pre-mRNA that is
predicted when the rate for cs is 11.39 (as inferred for Ribo1) does
not fit the new data, see Figure 3B in Text S1.
The overestimation of lariat-exon2 by the model (Figure 2 C)
might be explained by a significant underestimation of the
degradation rate for this species. This rate has been determined
in the 39SSRibo1 ‘OFF’ strain where transcription is halted by
doxycycline, see Text S2. (A second experiment using alternative
primers confirms this result [23].) Alternatively, the assumption
made when modelling 3SSRibo1 that uncleaved lariat-exon2
would be able to complete 39 end maturation and contribute to the
total population of polyadenylated lariat-exon2 may be incorrect.
Modelling shows that polyadenylated lariat-exon2 may be the
product of polyadenylated pre-mRNA alone, with no contribution
from the co-transcriptional pathway.
Discussion
Despite the biochemical and genetic evidence for multiple steps
in the cycle of splicing events, previous in vivo studies of mRNA
splicing kinetics have revealed simple first-order monomolecular
reactions that exclude the action of a catalyst. The allosteric
cascade is yet to be revealed at the systems level, either in terms of
the existence of multiple steps, or the impact of enzyme kinetics,
and we argue that this is due to the course-graining phenomena
associated with stochastic processes [39] and to the lack of
experimental quantification of mRNA and its precursors.
Using rapid sampling of cultures, combined with RT-qPCR
assays that detect the intermediates and products of the splicing
reaction in a way that permits quantitative comparisons between
different RNA species and between different cultures, we are able
to present kinetic data with an unprecedented level of resolution,
monitoring pre-mRNA production, the two steps of splicing and 39
end processing of a reporter transcript in yeast. Our data cannot
be explained satisfactorily by single-step unimolecular splicing
reactions. We conclude that a systems model of transcription and
splicing must distinguish the two steps of splicing, account for their
occurrence co- and post-transcriptionally, represent spliceosome
assembly, and include the action of an additional partner in the
splicing reactions, as we find evidence in the data for each of these
processes.
While developing the model, we considered including a
transition from uncleaved lariat-exon2 to polyadenylated lariat-
exon2, which would permit pre-mRNAs that have already
undergone the first step of splicing co-transcriptionally to undergo
39 end maturation. However, when this transition was added to
model I, the AIC was found to increase by 1.4 (after optimisation),
meaning model I fits the data better without the additional
transition. The proposed transition occurs very slowly, and
consequently rarely, does not assist modelling the data, and,
therefore, was excluded from the models we analysed further.
The model proposed here specifies that pre-mRNAs that have
already undergone the first step of splicing co-transcriptionally will
be fully spliced co-transcriptionally prior to 39 end cleavage. This
is in contrast with the mammalian model proposed in [40] where
splicing is completed after 39 cleavage (in HeLa nuclear extracts).
Both models stipulate that partially-spliced transcripts are not
released from the DNA, and both allow for a post-transcriptional
splicing pathway. Our model is consistent with the recycling of
splicing factors [3]. Recycling of BBP and Mud2 has been
proposed for pre-spliceosome formation [38], and similar
mechanisms may exist for subsequent spliceosome assembly steps.
Alternatively, it has been proposed that an increase in the local
concentration of splicing factors is linked to transcription via the
C-terminal domain of Pol II [15]. Nuclear speckles may also have
a role in keeping spliceosomal components concentrated near
nascent transcripts [37]. Cooperativity in the interaction of
splicing factors with the spliceosome or with the nascent pre-
mRNA may also contribute to the kinetics of co-transcriptional
splicing.
Addressing the interdependency between RNA processing steps,
modelling indicates that mutations at the 39 and 59 splice sites
reduce the rate of initiation of transcription, and, in the 39SS
mutant, reduce the probability of step one of splicing occurring co-
Kinetics of Co-Transcriptional Splicing
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establishing a parameterised model for the ‘wild type’ in order to
define and test the alternative explanations of the differences
observed.
A half life for splicing in HeLa cell nuclear extracts of 23 min
(splicing rate of 0.03/min) has been reported [15]. In vivo half-lives
of 6–12 min have been reported in mammalian cells [41], as have
estimates of 5–10 min for the completion of splicing after intron
synthesis [42]. Half lives for splicing in the range 0.4–7.5 min have
also been reported for the splicing of introns in mammalian cells
[43]. The inferred rates for post-transcriptional splicing in Ribo1
equate to half lives of 0.6 min for each of steps one and two, and
are at the faster end of the spectrum reported in [43]. On the co-
transcriptional pathway, splicing step one is concurrent with the
transcription of the 800 bases from the branchsite until the polyA
site (taking approximately 11 s). Co-transcriptional step two occurs
with a half life of 110 s for the first transcript, and, with feedback,
the half life reduces to 5.5 s at 670 s after induction. Therefore co-
transcriptional splicing is the more efficient pathway under the
high induction conditions studied here.
This study proposes a mechanistic kinetic model that represents
some of the complexity and flexibility of the splicing pathway that is
known from biochemical and genetic studies [3]. Co-transcriptional
splicing is evident in the data, and modelling shows that this
pathway may be activated after a delay. Furthermore, the second
step of splicing benefits from positive feedback when co-transcrip-
tional. These could be explained by the coordination of splicing
factor recruitment/recycling with transcription, possibly facilitated
by polymerase pausing [10,11] and/or dynamic chromatin
modification [9,44,45].
Materials and Methods
Strains and RT-qPCR
To analyse the transcription, splicing, degradation and 39 end
formation of yeast pre-mRNA, the Ribo1 reporter was integrated
into the yeast genome at the his3 locus. The reporter is based on a
hybrid ACT1/PGK1 gene [31], modified as described in [23] by
inserting two copies of the l boxB sequence (57 bp each) in the
ACT1 intron, enabling it to be readily distinguished by RT-qPCR
from the endogenous ACT1 intron without affecting splicing.
Primer pairs were created to measure the unspliced pre-mRNA
(59 primer upstream of ATG, 39 primer over the exon 1 - intron
junction), the lariat-exon2 intermediate (59 primer upstream of
39end of intron, 39 primer over exon 2; the pre-mRNA level was
subtracted from this measurement) and the spliced mRNA (59
primer upstream of ATG, 39 primer over exon 2). Measurements
of mRNA in copies per cell, averaged over a population, were
obtained by carefully quantifying the efficiency of cell lysis,
recovery of RNA, reverse transcription and qPCR. For full details
see [23].
Modelling the RT-qPCR signal
The first step of post-transcriptional splicing, and all transitions
to the fi path, decrease pre-mRNA and increase lariat-exon2. The
second step of splicing decreases lariat-exon2 and increases spliced
mRNA, according to the pathway. All species in the pathway, with
the exception of the excised intron product of step two, are
measurable by RT-qPCR, provided that they extend beyond the
position of the cDNA primer. Splicing events on transcripts that
have not been elongated to the cDNA point are not detected until
this sequence is transcribed, and the calculation of RT-qPCR
signal intensity from the species in the pathway reflects this. For
example, the (simulated) pre-mRNA signal is not incremented
until the e21 species is incremented, despite the PCR primers for
pre-mRNA being located several hundred bases upstream.
Considering a single Pol II complex (and ignoring the effect of
other Pol IIs on its movement), the probability of transitioning from
states e15::e39 to the co-transcriptional path is simply calculated from
the elongation rate and the transition rate. This choice can be made
25 times, allowing the probability of the Pol II exiting on the post-
transcriptional pathway to be estimated independently of ke by:
(1 { (ke=cs)=(kez(ke=cs)))
25~
(1 { 1=(1zcs))
25 ð1Þ
Unless otherwise stated, reaction rates are expressed as the
probability density per unit time, per distinct combination of
reactant molecules. Where there is a single reactant species, the
number of distinct combinations is just the population of reactants.
The half life is the time a molecular species takes to reduce by half,
and is computed for unimolecular reactions by ln2=stochastic{
rate{constant in units of seconds.
Pathway optimisation and comparison
Pathway models were optimised by the simulated annealing
algorithm specified in [35] (see Figure 1). Following [35], the error
E is defined by equation 2 where S is a time series simulated from a
pathway model, D is the observed data, n is the number of time
points and d the number of dependent variables (the dimension of
Di and Si is d).
E~
X n
i~1
(Si{Di)
2=d:n ð2Þ
On each iteration of the algorithm, each parameter pi is assigned a
new value (p’ i) and the error for the new set of parameters (E’)i s
calculated from a simulation of the model using the updated
parameter set. The new parameter value is always accepted if
E’vE, otherwise it is accepted with probability e(E’{E)=T, where T
is the current temperature and E is the error of the current
parameter set. The new parameter value is generated from the
current value by adding a normally-distributed random value. We
define the scale constant k in equation 3 using the error of a set of
parameter values that are given as input at the start of optimisation
(these mustprovide an approximate fit to the data), and then update
each parameter value according to equation 4, where N(0,1) is a
normally-distributed random value (mean 0, standard deviation 1)
and pmax
i and pmin
i are the maximum and minimum values
respectively that pi is allowed to take. See [35] for further details.
k~1=ln(
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Estart
p
z1) ð3Þ
p’ i~pizkln(
ﬃﬃﬃﬃ
E
p
z1)N(0,1)(pmax
i {pmin
i )=2 ð4Þ
The Akaike information criterion (AIC; eqn. 5) was used to
assess the fit between a time series S simulated from a pathway
model of k optimised parameters, a data set D of n values [46].
Assuming normally distributed errors, AIC can be computed from
the model residuals (eqn. 6) [47]. The values for total AIC
incorporate the 2k penalty for the number of parameters
optimised.
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~nln(
X n
i~1
(Si{Di)
2=n)z2k ð6Þ
When comparing m pathway models, the Akaike weight wi of
model i can be defined in terms of the relative likelihood e{Di=2,
where Di is the difference between the AIC for model i and the
AIC of the best model [47]. Akaike weights computed by
equations 7 and 8 are listed in Table 1 .
Di~AICi{AICbest ð7Þ
wi~e{Di=2=
X m
j~1
e{Di=2 ð8Þ
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